In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer. Bouchmaa N, Ben Mrid R, Bouargalne Y, Ajouaoi S, et al. PLoS One 2023;18:e0272781.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bouchmaa N, Ben Mrid R, Bouargalne Y, Ajouaoi S, et al. In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer. PLoS One 2023;18:e0272781.
PMID: 36757991